Creo Medical Group Plc (CREO.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 06-2018 | 06-2017 | 02-2016 | 02-2015 | |
| Cash Flows From Operating Activities | |||||
| Income taxes - deferred | -2,704 | -2,893 | -1,143 | N/A | N/A |
| Accounts receivable | -553 | -112 | -66 | -320 | 195 |
| Other Working Capital | 2,306 | 379 | 537 | -114 | 241 |
| Other Operating Activity | -10,902 | -8,760 | -6,243 | -2,692 | -2,711 |
| Operating Cash Flow | $-11,852 | $-11,385 | $-6,915 | $-3,126 | $-2,275 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -484 | -1,561 | -224 | -146 | -61 |
| Purchase Sale Intangibles | -634 | -21 | -1 | 0 | 0 |
| Other Investing Activity | 311 | 9 | 5 | 7 | 3 |
| Investing Cash Flow | $-807 | $-1,573 | $-220 | $-139 | $-58 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 49,306 | 598 | 20,012 | 5,526 | 1,750 |
| Common Stock Repurchased | N/A | -35 | -12 | 0 | 0 |
| Other Financing Activity | -187 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $49,119 | $563 | $20,001 | $5,526 | $1,750 |
| Beginning Cash Position | 44,589 | 27,378 | 823 | 305 | 888 |
| End Cash Position | 81,048 | 14,982 | 13,689 | 2,567 | 305 |
| Net Cash Flow | $36,460 | $-12,395 | $12,865 | $2,262 | $-582 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,852 | -11,385 | -6,915 | -3,126 | -2,275 |
| Capital Expenditure | -1,118 | -1,606 | -226 | -146 | -61 |
| Free Cash Flow | -12,970 | -12,991 | -7,140 | -3,271 | -2,336 |